One of the most famous examples, mutations in BRCA1/BRCA2 genes, have given patients the ability to reliably assess their risk of developing breast cancer in their lifetime, as well as their risk of relapse after a first bout of breast cancer. Here, BRCA2 is linked to breast carcinoma.